Takeda To Manufacture 50% Of Its Dengue Vaccines In India

NDTV Profit

Takeda To Manufacture 50% Of Its Dengue Vaccines In India

Japanese drugmaker Takeda Pharmaceutical Co. announced a strategic partnership with Indian vaccine and biologics company Biological E. Ltd. to manufacture its dengue vaccine, TAK-003.The Indian partner is expected to "scale up its production capacity to potentially reach 50 million doses annually," the company said in a Feb. 27 release.This is further expected to accelerate Takeda's efforts to manufacture 100 million doses annually within the de…